Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1984 1
1985 1
1986 1
1987 1
1988 3
1989 2
1990 1
1992 3
1993 4
1994 3
1995 1
1996 1
1997 1
1998 1
1999 4
2000 7
2001 1
2002 2
2003 1
2004 3
2005 2
2006 3
2007 2
2008 3
2009 6
2010 5
2011 5
2012 4
2013 1
2014 3
2015 2
2016 1
2017 1
2018 2
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Chronic myeloid leukemia in Asia.
Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar S, Kim DW, Kweon IY, O'Neil WM, Saikia TK, Wang J. Au WY, et al. Among authors: jootar s. Int J Hematol. 2009 Jan;89(1):14-23. doi: 10.1007/s12185-008-0230-0. Epub 2008 Dec 20. Int J Hematol. 2009. PMID: 19101781 Review.
Amifostine and hematologic effects.
Sriswasdi C, Jootar S, Giles FJ. Sriswasdi C, et al. Among authors: jootar s. J Med Assoc Thai. 2000 Apr;83(4):374-82. J Med Assoc Thai. 2000. PMID: 10808697 Review.
CML treatment in Asia-Pacific region.
Jootar S. Jootar S. Hematology. 2012 Apr;17 Suppl 1:S72-4. doi: 10.1179/102453312X13336169155772. Hematology. 2012. PMID: 22507785
A prospective randomized study of Chop versus Chop plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: the International Oncology Study Group NHL1 Study.
Giles FJ, Shan J, Advani SH, Akan H, Aydogdu I, Aziz Z, Azim HA, Bapsy PP, Buyukkececi F, Chaimongkol B, Chen PM, Cheong SK, Ferhanoglu B, Hamza R, Khalid HM, Intragumtornchai T, Kim SW, Kim SY, Koc H, Kumar L, Kumar R, Lei KI, Lekhakula A, Muthalib A, Patel M, Poovalingam VP, Prayoonwiwat W, Rana F, Reksodiputro AH, Ruff P, Sagar TG, Schwarer AP, Song HS, Suh CW, Suharti C, Supindiman I, Tee GY, Thamprasit T, Villalon AH, Wickham NR, Wong JE, Yalcin A, Jootar S; International Oncology Study Group NHL1 Study. Giles FJ, et al. Among authors: jootar s. Leuk Lymphoma. 2000 Dec;40(1-2):95-103. doi: 10.3109/10428190009054885. Leuk Lymphoma. 2000. PMID: 11426633 Clinical Trial.
Serum erythropoietin levels in thalassemia major and intermedia.
Chaisiripoomkere W, Jootar S, Chanjarunee S, Ungkanont A. Chaisiripoomkere W, et al. Among authors: jootar s. Southeast Asian J Trop Med Public Health. 1999 Dec;30(4):786-8. Southeast Asian J Trop Med Public Health. 1999. PMID: 10928378
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).
Do YR, Kwak JY, Kim JA, Kim HJ, Chung JS, Shin HJ, Kim SH, Bunworasate U, Choi CW, Zang DY, Oh SJ, Jootar S, Reksodiputro AH, Lee WS, Mun YC, Kong JH, Caguioa PB, Kim H, Park J, Kim DW. Do YR, et al. Among authors: jootar s. Br J Haematol. 2020 Apr;189(2):303-312. doi: 10.1111/bjh.16381. Epub 2020 Feb 3. Br J Haematol. 2020. PMID: 32012231 Free PMC article. Clinical Trial.
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia.
Kim H, Kim S, Kim HJ, Kim YK, Kwak JY, Yhim HY, Kim SH, Do YR, Oh S, Lee SE, Jootar S, Cui JW, Kim DW. Kim H, et al. Among authors: jootar s. Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e391-e399. doi: 10.1016/j.clml.2018.06.031. Epub 2018 Jul 4. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30082224 Free article.
79 results